As filed with the Securities and Exchange Commission on May 18, 2020
Registration No. 333-238128
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Amendment
No. 1
to
FORM S-3
REGISTRATION STATEMENT
UNDER
THE
SECURITIES ACT OF 1933
CLEARSIDE BIOMEDICAL, INC.
(Exact name of registrant as specified in its charter)
|
|
|
Delaware
|
|
45-2437375
|
(State or other jurisdiction of
incorporation or organization)
|
|
(I.R.S. Employer
Identification Number)
|
900 North Point Parkway, Suite 200
Alpharetta, Georgia 30005
(678) 270-3631
(Address, including zip code, and telephone number, including area code, of registrants principal executive offices)
George Lasezkay, Pharm.D., J.D.
President and Chief Executive Officer
Clearside Biomedical, Inc.
900 North Point Parkway, Suite 200
Alpharetta, Georgia 30005
(678) 270-3631
(Name, address, including zip code, and telephone number, including area code, of agent for service)
Copy to:
Brent
B. Siler
Brian F. Leaf
Mark Ballantyne
Cooley
LLP
11951 Freedom Drive
Reston, VA 20190
(703) 456-8000
Approximate date of
commencement of proposed sale to the public: From time to time after this Registration Statement becomes effective.
If the only securities being
registered on this Form are being offered pursuant to dividend or interest reinvestment plans, please check the following box: ☐
If any
of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933, other than securities offered only in connection with dividend or interest reinvestment plans,
check the following box: ☒
If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the
Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐
If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement for the same offering. ☐